Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 926.70
-26.40 (-2.77%)
At close: Jan 30, 2026
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 276.54 million as of January 30, 2026. Its market cap has increased by 2.31% in one year.
Market Cap
276.54M
Enterprise Value
230.09M
Revenue
n/a
Ranking
n/a
PE Ratio
250.65
Stock Price
926.70
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 276.54M, a decrease of -77.06%. That is a compound annual growth rate of -30.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 276.54M | 51.76% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.12B |
| Danel (Adir Yeoshua) | 2.80B |
| BrainsWay | 1.52B |
| Kamada | 1.50B |
| Novolog (Pharm-Up 1966) | 634.51M |
| Bonus BioGroup | 478.85M |
| Geffen Residence & Renewal | 258.75M |
| Golden House | 175.34M |